SAB BIOTHERAPEUTICS, INC. (SABS) Shareholders’ equity 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) shareholders’ equity at each fiscal year-end, per SEC filings.
$151.5MFY2025 · since FY2020: $39.0M → $151.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $151.5M | +483.3% |
| FY2024 | $26.0M | -54.7% |
| FY2023 | $57.3M | +84.5% |
| FY2022 | $31.1M | -19.4% |
| FY2021 | $38.5M | -1.2% |
| FY2020 | $39.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice